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  Carmonam （CR］iN（［N）， the first monobactam antibiotic in Japan， has excellent activity against
gram－negative bact・eria and is useful in the treatment of urinary ttac． t infections． However， it
may be insufficient in the treatment of complicated urinary tract infections because of the increase
ifi isolation of gram－positive bacteria， and it may be necessary ・to co－qdminister antibiotics active
against gram－positive organisms to achieve a broader spectrum of coverage in connection with
severe infecti6ns． The combination of CRMN and fosfomycin （FOM） was eva1uated for its
effectiveness and safety at the Department of Urology， Yamagata University Hospital and 7 affil－
iated hospitals．
  Clinical efficacy was assessed on 64 patients with complicated urinary tract infection according
to the Criteria for Clinical Evaluation of Antimicrobial Agents in UTI （3rd． ed．） recommended
by the Japan UTI Committee． Clinical efficacy was evaluated as excellent in 16， moderate in
32， poor in 16， with an overall clinical effectiveness rate of 75．0％， which is superior compared
with CRMN alone．
＊：現仙台社会保険病院院長
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Of the total of 92 bacterial strains isolated， 66 （71．7％） were eradicated．
Subjective’adverse reaction was seen in 1 patient （1．4％）， as nausea and anorexia． Slight
increases in serum GOT and GPT ware ．recorded in 5 patients （7．190 ）． These findings disappeared
after the termination of administration without treatment．
  The combination of CRMN and FOM might therefore be useful in the treatment of compli－
cated urinary tract infections．
                                 （Acta Urol． 36； 731一一735， 1990）
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Table 1． Overall clinical efficacy
  膿尿
ﾗ菌尿
正常化 改 善 不 変 細菌尿に
ﾎする効果
陰性化 16 14 6 36（56．3％）
減 少 2 5 3 10（15．6％）



















Table 2． OVerali，clini．cal ．efficacy classified by infection type
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小 計 34 （53．1010） 3 19 1264．7e！o
計 64 （1000f，） 16 32 1675．Oole
Table 3． Bacteriological responseTable 4． Strains appearing after treatment











































































小  計 25 6 80 ．50／e
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■■著効  彫有効  騒翻無効
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Fig． 2． Overall clinical efficacy of the combination of
    CRMN and FOM． and CRMN only
CRMN十FOM
  ■陰性化  ％減少  麗菌交代
O 20 40 60 80
  CRMN単独
Fig． 3． Effect on bacteriuria of the combination
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Fig． 4． Effect on pyuria of the combination of CRMN





















■著効  盟有効 暖璽無効























Fig． 5． Overall clinical efficacy of the combination of
    CRMN and FOM， and CRMN only classified by
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